|
Albert David to set up facility to
manufacture oral solids and liquids
CITY-BASED pharmaceutical company Albert David
Limited, established more than seven decades ago, is planning to set up
a new state-of-the-art manufacturing facility on the outskirts of the
city as a part of its modernization and up gradation plans. Currently,
the company manufactures and markers a wide range of pharmaceutical
finished dosage form for different therapeutic segments, medical
disposables and a wide-range of IV fluids.
Confirming the development, Kamal Prasad Mundhra, executive director of
Albert David Limited told Express Pharma Pulse, “The company has decided
on principle to set up a state-of-the-art manufacturing facility in and
around the city”. “We are already scouting for proper land to set up
this new manufacturing facility, which will adhere to all the
international specifications like Cgmp, WHO & FDA norms, “he informed.
“We will be soon zeroing on the land and the construction will commence
immediately. The new facility to be set up at a cost of Rs. 40 crore, is
likely to come up in the next two years time, “Mundhra added. “The new
facility is likely to manufacture oral solids and liquids, ointments and
some bulk drugs. The state-of-the-art manufacturing facility will help
us to substantially bring down the per unit cost of production of
medicine”, he said.
The company has also decided to upgrade its R&D has also decided to
upgrade its R&D facilities. The new R&D facility will e housed in the
proposed manufacturing unit. Albert David Limited, is a part of the GD
Kothari Group of companies having diverse interests in textiles,
engineering items, tea plantations, chemicals, salt processing and
international trading. The company’s turnover stood at Rs. 115 crore in
the last financial year (2003-04). The company exports its products to
countries in Europe, Africa and in the US. At present, the company is
operating in major therapeutic segments like NS-AIDs, herbal drugs,
anti-bacterials, anti-ulcerants, neurotropics, anxiolytics, small and
large volume parentals, dermatological products and disposable syringes
and needles. The company is a leader in human placental extract therapy.
Placentrex, one of the largest-selling products of the company is
celebrating its ‘golden jubilee’ this year:
In a related development, the company has also decided to increase the
production capacity of its Ghaziabad factory in Uttar Pradesh producing
a wide range of IV fluids.
Top
Back to Press Clippings
|
